AtriCure, Inc.

AtriCure, Inc. is an American medical device company specializing in cardiac ablation and left atrial appendage exclusion technologies. Headquartered in Pleasanton, United States. Here are key aspects of the company:

• Products & Services: Hybrid AF™ Therapy for long-term Afib burden reduction using the AtriClip PRO-Mini® device designed for minimally invasive procedures.
• Products & Services: Surgical ablation integration with CABG procedures to improve long-term survival and reduce new-onset Afib in patients without a history of Afib but having risk factors.
• Products & Services: Cryo Nerve Block technology providing durable approaches to post-amputation pain management for limb loss patients. AtriCure supports over 750,000 treated patients through its portfolio of devices aimed at reducing serious complications like stroke and heart failure while advancing evidence-based cardiac care strategies.